Heart Rhythm Devices
Sort by:
Boston Scientific
S-ICD as a first-line therapy: Results from the PRAETORIAN & UNTOUCHED Trials
Nov. 05, 2020
Faculty:
Boston Scientific
,
Michael Gold
,
Reinoud Knops
,
Ulrika Birgersdotter-Green
- 1 view
- November 5, 2020
Boston Scientific
Integrated Heart Failure Patient Management — EP and HF Perspective
Sep. 22, 2021
Faculty:
Boston Scientific
,
Marat Fudim
,
Adrian Hernandez
,
Camille Frazier-Mills
- 4 views
- September 22, 2021
[REMOVED] ConvaTec
Risk Mitigation of Infection and Post-Operative Wound Complications Following CIED Surgery (Panel Discussion Included)
Jul. 28, 2020
Faculty:
ConvaTec
,
Theofanie Mela
,
Charles Love
,
Peter Belott
,
Bruce Wilkoff
- 11 views
- July 28, 2020
Boston Scientific
WATCHMAN: An Alternative to OACs
FEATURING
Tadeo Diaz Balderrama,
Rakesh Shah
- 4 views
- February 12, 2024
CVRx | Barostim
Beyond BeAT-HF: Real World Experience with Barostim
FEATURING
Gurusher Panjrath
- 15 views
- April 24, 2024
CVRx | Barostim
Patient Identification and Post-Implant Management within an Advanced Heart Failure Program
FEATURING
Dmitry Yaranov
- 15 views
- April 24, 2024
CVRx | Barostim
Long-Term Results of the BeAT-HF Clinical Study
FEATURING
JoAnn Lindenfeld
- 17 views
- April 24, 2024
Boston Scientific
WATCHMAN: The Referring Process
FEATURING
Tadeo Diaz Balderrama,
Rakesh Shah
- 18 views
- February 12, 2024
Boston Scientific
Protect your patients: Stroke risk reduction without the risks of OACs
- 18 views
- February 12, 2024
Cardiopulmonary Research Science and Technology Institute
Management of the Left Atrial Appendage During Cardiac Surgery
FEATURING
Patrick McCarthy
- 18,965 views
- May 8, 2013
- 34
ACC 2022 Conference Coverage
ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendations for HFrEF and HFmrEF Treatment
FEATURING
Paul Heidenreich
- 18,578 views
- April 21, 2022
- 58
CVRx | Barostim
Challenges and Opportunities with Contemporary GDMT (Dr. Heywood)
FEATURING
J. Thomas Heywood
- 35 views
- April 24, 2024
Congenital and Structural Interventions
LAA Closure for Atrial Fibrillation using Occlusion Device
FEATURING
Horst Sievert
- 8,504 views
- April 5, 2013
- 33
CVRx | Barostim
HFA 2023: Unlocking the Potential of Baroreflex Activation in Heart Failure Patients (Discussion)
- 192 views
- October 11, 2023
- 4
The Texas Heart Institute
Rhythm vs Rate: Has the Tide Changed Since the AFFIRM Trial?
FEATURING
Mehdi Razavi
- 5,717 views
- November 12, 2021
- 44
CVRx | Barostim
ESC 2023: BeAT-HF: Long term outcome
FEATURING
Michael Zile
- 101 views
- October 4, 2023
- 1
CVRx | Barostim
HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes
FEATURING
Faiez Zannad
- 110 views
- October 2, 2023
- 1
CVRx | Barostim
VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure (Part 2)
FEATURING
Clement Darling
- 74 views
- August 31, 2023
CVRx | Barostim
VAM 2023: Baroreflex Activation Therapy - A Novel Extravascular Procedure for Heart Failure (Discussion)
FEATURING
Clement Darling,
MANUEL PEREZ-IZQUIERDO
- 74 views
- August 31, 2023
All Topics:
Baroreflex Activation Therapy
Cardiac Contractility Modulation (CCM) Therapy
Cardiac Resynchronization Therapy (CRT)
Coronary Sinus Cannulation
External Cardiac Defibrillator
His-Bundle Pacing
Implantable Cardioverter Defibrillator (ICD)
LAA Closure
Leadless Pacemaker
Lead Management
Left Bundle Branch Block (LBBB)
Pacemaker
Remote Monitoring